These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 4789063)
1. Intermittent low molecular weight dextran infusions in the management of ischemic skin disorders. Holti G Bibl Anat; 1973; 11():359-63. PubMed ID: 4789063 [No Abstract] [Full Text] [Related]
2. The effect of low molecular weight dextran on the krypton 85 uptake from the skin of ischaemic limbs. Brown AH J Cardiovasc Surg (Torino); 1973; 14(2):215-9. PubMed ID: 4714953 [No Abstract] [Full Text] [Related]
3. Low-molecular-weight dextran in the treatment of experimental frostbite. Webster DR; Bonn G Can J Surg; 1965 Oct; 8(4):423-7. PubMed ID: 5834732 [No Abstract] [Full Text] [Related]
4. Low molecular weight dextran therapy for digital ischemia due to collagen vascular disease. Berglund B; Swanbeck G; Hedin H Dermatologica; 1981; 163(4):353-7. PubMed ID: 6171463 [TBL] [Abstract][Full Text] [Related]
5. Blood fibrinolytic activity in diseases of small blood vessels and the effect of low molecular weight dextran. Cunliffe WJ; Menon IS Br J Dermatol; 1969 Mar; 81(3):220-5. PubMed ID: 5775073 [No Abstract] [Full Text] [Related]
6. Dextran 40 in the treatment of peripheral vascular diseases. Thomas JM; Silva JR Arch Surg; 1973 Feb; 106(2):138-41. PubMed ID: 4686516 [No Abstract] [Full Text] [Related]
7. Failure of low molecular weight dextran infusions in scleroderma. Kirk JA; Dixon AS Ann Rheum Dis; 1969 Jan; 28(1):49-54. PubMed ID: 5786283 [No Abstract] [Full Text] [Related]
8. Continuous intra-arterial infusion therapy with dextran in the treatment of ischemic conditions of the extremities. Skalkeas G; Balas P; Katsogiannis A; Karagianakos P Bibl Anat; 1969; 10():158-67. PubMed ID: 5407355 [No Abstract] [Full Text] [Related]
9. Low-molecular-weight dextran in the treatment of peripheral arterial insufficiency. Singer A Lancet; 1965 Nov; 2(7421):1050-2. PubMed ID: 4159137 [No Abstract] [Full Text] [Related]
10. Drugs five years later: dextran 40. Data JL; Nies AS Ann Intern Med; 1974 Oct; 81(4):500-4. PubMed ID: 4606455 [No Abstract] [Full Text] [Related]
11. [Changes in some plasma parameters in the course of dextran 40]. Bartolo M; Solitro A; Vaccaro E; Arcuri P; Altieri V Minerva Med; 1975 May; 66(36):1704-19. PubMed ID: 1128815 [TBL] [Abstract][Full Text] [Related]
13. Low molecular dextran in the management of frostbite in monkeys. Kapur BM; Gulati SM; Talwar JR Indian J Med Res; 1968 Nov; 56(11):1675-81. PubMed ID: 4975427 [No Abstract] [Full Text] [Related]
14. [Death caused by infusion of low-molecular dextran]. Plamieniak L; Kowal-Gierczak B; Kotschy M; Kurzawska M; Kozlowska B Wiad Lek; 1974 May; 27(10):901-5. PubMed ID: 4839858 [No Abstract] [Full Text] [Related]
15. [Intravascular disseminated coagulation syndrome during treatment with dextran 40]. Wlodarczyk J; Kotschy M; Janukowiez-Lorenz H; Kurzawska M; Prastowski W; Rychlik W Pol Tyg Lek; 1975 Feb; 30(7):297-9. PubMed ID: 1167691 [No Abstract] [Full Text] [Related]
16. The role of dextran in severe ischemic extremity disease and arterial reconstructive surgery. A review. Bergqvist D; Bergentz SE Vasa; 1983; 12(3):213-8. PubMed ID: 6195843 [No Abstract] [Full Text] [Related]
17. [Value of iterative perfusions with low molecular weight dextran in long-term treatment of retinal venous occlusions]. Cordier J; Raspiller A; Bowyer M; Vouters H Bull Soc Ophtalmol Fr; 1978 Nov; 78(11):795-9. PubMed ID: 755549 [No Abstract] [Full Text] [Related]
18. The effect of intermittent low molecular dextran infusions upon the digital circulation in systemic sclerosis. Holti G Br J Dermatol; 1965 Nov; 77(11):560-8. PubMed ID: 5853250 [No Abstract] [Full Text] [Related]
19. Disordered blood coagulation in burned children receiving high molecular weight dextran. Thomas T; Morris A; Rose MS J Clin Pathol; 1972 Jun; 25(6):473-7. PubMed ID: 5043372 [TBL] [Abstract][Full Text] [Related]